In this context, the DNA sequencing studies of 7,416 human cancers of different tissular origin found very frequent deletions in cis-regulatory regions of the IRS-4 gene and it has been established as an oncogenic driver [12, 21]. This evidence concerns the gene IRS4 and cancer.